BioSpecifics (BSTC) Announces $2M Common Buyback
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Join SI Premium – FREE
BioSpecifics Technologies Corp. (Nasdaq: BSTC) announces $2 million common stock buyback.
This decision reflects the Company's continued commitment to increasing value for its stockholders and its confidence that it will achieve its goals.
This decision reflects the Company's continued commitment to increasing value for its stockholders and its confidence that it will achieve its goals.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- N-able expands share repurchase program by $50 million
- Jazz Pharmaceuticals plans $1B note offering and share buyback
- BMO plans to buy back up to 25 million common shares
Create E-mail Alert Related Categories
Stock BuybacksRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
